Immunohistochemically, the tumor cells were positive for HepPar1 and negative for CK19, with a Ki-67 labeling index of approximately 40%, confirming the diagnosis of HCC (Fig. 4). This evidence concerns the gene KRT19 and hepatocellular carcinoma.